Document › Details

Roche. (2/3/10). "Press Release: Strong Operating Performance for Roche in 2009. Record Sales, Double-digit Growth in Operationg Profit and Core Earnings per Share – Dividend Increase by 20% to 6.00 Swiss Francs Proposed". Basel.

	Organisation	Roche (Group)
	Organisation 2	Genentech Inc. (NYSE: DNA)
	Group	Roche (Group)
	Product	Avastin®
	Product 2	Tamiflu
	Index term	Annual Report
	Index term 2	Genentech–Roche: investment, 200901–200903 cash tender offer to acquire remaining 44.2% for $95/share
	Person	Schwan, Severin (200601 Roche Diagnostics CEO Division designated Roche Group CEO 200803)
	Person 2	Levinson, Arthur D. (Genentech 200603 CEO)

Record changed: 2010-07-21

More documents for Roche (Group)

• [1] –. (8/23/10). "News: Federal Court Upholds Decision Against Qiagen". New York....
• [2] Roche. (8/23/10). "Press Release: Roche Acquires BioImagene, a Leading Provider of Digital Pathology Laboratory Solutions. Acquisition further Strengthens Roche’s Global Leadership in Tissue-based Cancer Diagnostics and Research". Basel....
• [3] Roche. (8/19/10). "Press Release: IMGM Laboratories GmbH and the Center for Human Genetics and Laboratory Medicine to Develop Workflows for Use of 454 Sequencing Systems in Human Genetics". Penzberg....
• [4] Roche. (7/15/10). "Press Release: Identification of Valid Endogenous Control Genes for Determining Gene Expression in Human Glioma Using the Roche RealTime ready Human Reference Gene Panel". Penzberg....
• [5] Roche. (7/13/10). "Press Release: Macrogen, Inc. Certified as NimbleGen Array Service Provider in Korea". Madison, WI....
• [6] Roche. (7/12/10). "Press Release: U.S. and Norwegian Scientists Use 454 Sequencing Systems to Identify a Novel Virus Threatening Farmed and Wild Salmon". Branford, CT....
• [7] Roche. (7/8/10). "Press Release: A New Study Shows that Testing for Human Papillomavirus Genotypes 16 and 18 Detects Cervical Pre-cancer Missed by Pap Test". Basel....
• [8] Roche. (7/8/10). "Press Release: High-resolution Melting Analysis Using the Roche LightCycler Instrument for Rapid and Reliable Methylation Detection in Archival Tissue Samples". Penzberg....
• [9] Roche. (7/7/10). "Press Release: Roche Submits Applications to FDA for Trastuzumab-DM1 in Previously Treated Advanced HER2-positive Breast Cancer. T-DM1 Is the First Antibody-drug Conjugate in Roche’s Pipeline to Be Submitted to the FDA". Basel....
• [10] Roche. (7/6/10). "Press Release: Relaunch – »Roche Applied Science Industrial Business« Now Is »Roche Custom Biotech«". Penzberg....

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]
» top

The use of this website requires to accept the disclaimer! A project of [iito] Business Intelligence © 2002-2010. Made in Germany.